Implications of biosimilars for the future

  • Johnson P
  • 28

    Readers

    Mendeley users who have this article in their library.
  • 10

    Citations

    Citations of this article.

Abstract

Historical perspective on the use of biotechnology for drug product development, terminology used for biotechnology drug products, potential benefits of biotechnology, applications of biotechnology to drug product development, pharmacy considerations in the use of biopharmaceuticals, and the classification of biotechnology products by the Food and Drug Administration (FDA) are discussed.

Author-supplied keywords

  • Biologicals
  • Biotechnology
  • Classification
  • Equivalency, therapeutic
  • Food and Drug Administration (U.S.)
  • Nomenclature
  • Pharmacists
  • Product development

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Philip E. Johnson

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free